AI has the power to transform how organizations derive insights, make decisions, and unlock value, but all that depends on the quality of the data. Most AI initiatives fail not because of algorithmic ...

Developing new drugs is risky and expensive. Creating a new drug and bringing it to clinical trials can cost billions of pounds, with no guarantees of success. And sometimes a drug can fail to meet ...